New Survey Highlights Pill-Splitting Challenges in Parkinson's Disease Treatment
PR Newswire —
ALPHARETTA, Ga., Jan. 27, 2026 /PRNewswire/ -- Avion Pharmaceuticals, an Alora Pharmaceuticals subsidiary company focused on advancing treatment for Parkinson's disease, is proud to announce the findings from a recently published study examining the real-world practice of splitting...